{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:49:02Z","timestamp":1794948542368,"version":"4.9.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Corticosteroids are effective adjunct treatment for certain infectious diseases. However, their role in children with community-acquired pneumonia (CAP) remains unclear. We aim to assess the efficacy and safety of adjunct corticosteroid therapy in pediatric CAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      A systematic literature search was conducted on MEDLINE to retrieve studies assessing systemic corticosteroid therapy, given alongside antimicrobial regimens, in pediatric CAP (last search date December 31, 2024). Literature screening, quality assessment, and data extraction were conducted by 2 independent reviewers. Heterogeneity and publication bias were detected by\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      and Egger\u2019s tests. The data were pooled using the random-effects model for the conduction of meta-analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-two articles (N = 75.353) of 3799 screened studies were included in the systematic review; 7 of 22 studies providing data on length of hospital stay (LOS) and duration of fever for corticosteroid-treated versus control patients were included in the meta-analysis. Significant heterogeneity was observed regarding the regimen, dosage and duration of corticosteroid therapy. Regarding meta-analysis, LOS and time to defervescence were significantly decreased in patients receiving corticosteroids compared to controls in randomized clinical trials (Cohen\u2019s\n                      <jats:italic toggle=\"yes\">d<\/jats:italic>\n                      value = \u22120.59, 95% confidence interval: \u22120.96 to \u22120.23,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001\n                      <jats:italic toggle=\"yes\">, I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 52.6%; Cohen\u2019s\n                      <jats:italic toggle=\"yes\">d<\/jats:italic>\n                      value =-0.54, 95% confidence interval: \u22120.83 to \u22120.26,\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      0.001\n                      <jats:italic toggle=\"yes\">, I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 26.1%, respectively), but not in observational studies. Corticosteroid administration was associated with a shorter radiologic and clinical recovery time especially for\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      and viral pneumonia with wheezing. Corticosteroid-related adverse events were infrequent and manageable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our analysis suggests a possible advantage for corticosteroid therapy in selected pediatric patients with CAP. Further studies are needed to clarify how, when, and where corticosteroids should be added to the treatment plan of pediatric CAP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005106","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:00:12Z","timestamp":1765947612000},"page":"536-542","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Systemic Corticosteroids in Children With Pneumonia: \u0391 Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5059-6191","authenticated-orcid":false,"given":"Maria","family":"Geropeppa","sequence":"first","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Infectious Diseases Department \u201cMAKKA,\u201d First Department of Paediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Tsagkli","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Infectious Diseases Department \u201cMAKKA,\u201d First Department of Paediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papadatou","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Infectious Diseases Department \u201cMAKKA,\u201d First Department of Paediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, Athens Medical School, Athens, Greece"},{"name":"University Research Institute of Maternal and Child Health and Precision Medicine, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Efthymiou","sequence":"additional","affiliation":[{"name":"University Research Institute of Maternal and Child Health and Precision Medicine, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, Athens, Greece"},{"name":"First Department of Pediatrics, Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, Medical School, National and Kapodistrian University of Athens, Aghia Sophia Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Tagarro","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Instituto de Investigaci\u00f3n 12 de Octubre (IMAS12), Madrid, Spain"},{"name":"Department of Pediatrics, Infanta Sof\u00eda University Hospital, Fundaci\u00f3n Para la Investigaci\u00f3n Biom\u00e9dica e Innovaci\u00f3n Hospital Universitario Infanta Sof\u00eda y Hospital del Henares (FIIB HUIS HHEN), Universidad Europea de Madrid. Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Galanakis","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Heraklion University Hospital, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Infectious Diseases Department \u201cMAKKA,\u201d First Department of Paediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, Athens Medical School, Athens, Greece"},{"name":"University Research Institute of Maternal and Child Health and Precision Medicine, \u201cAghia Sophia\u201d Children\u2019s Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"R1-20260508","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(12)60907-6","article-title":"Tackling pneumonia and diarrhoea: the deadliest diseases for the world\u2019s poorest children.","volume":"379","author":"Gupta","year":"2012","journal-title":"Lancet"},{"key":"R3-20260508","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1045-1870(98)80031-9","article-title":"Bacterial pneumonia in children.","volume":"9","author":"Adler-Shohet","year":"1998","journal-title":"Semin Pediatr Infect Dis"},{"key":"R4-20260508","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/pch\/8.10.616","article-title":"Community-acquired pneumonia in children.","volume":"8","author":"Davies","year":"2003","journal-title":"Paediatr Child Health"},{"key":"R5-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia.","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20260508","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/CS20210879","article-title":"Pathogenesis of pneumonia and acute lung injury.","volume":"136","author":"Long","year":"2022","journal-title":"Clin Sci (Lond)"},{"key":"R7-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R8-20260508","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R9-20260508","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults.","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20260508","first-page":"CD002244","article-title":"Corticosteroids for managing tuberculous meningitis.","volume":"2016","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20260508","first-page":"CD004405","article-title":"Corticosteroids for acute bacterial meningitis.","volume":"9","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20260508","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.38181.482222.55","article-title":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.","volume":"329","author":"Annane","year":"2004","journal-title":"BMJ"},{"key":"R14-20260508","first-page":"CD007720","article-title":"Corticosteroids for pneumonia.","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-20260508","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.15-1733","article-title":"Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis.","volume":"149","author":"Wan","year":"2016","journal-title":"Chest"},{"key":"R16-20260508","doi-asserted-by":"crossref","first-page":"e47926","DOI":"10.1371\/journal.pone.0047926","article-title":"Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis.","volume":"7","author":"Nie","year":"2012","journal-title":"PLoS One"},{"key":"R17-20260508","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4187\/respcare.02758","article-title":"Corticosteroid therapy for severe community-acquired pneumonia: A meta-analysis.","volume":"59","author":"Cheng","year":"2014","journal-title":"Respir Care"},{"key":"R18-20260508","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Review).","volume":"2014","author":"Walters","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R20-20260508","doi-asserted-by":"crossref","first-page":"123","DOI":"10.53841\/bpsicpr.2020.15.2.123","article-title":"Cochrane handbook for systematic reviews of interventions.","volume":"15","author":"Higgins","year":"2020","journal-title":"Int Coach Psychol Rev"},{"key":"R21-20260508","first-page":"1","article-title":"Clinical features and \u201cearly\u201d corticosteroid treatment outcome of pediatric Mycoplasma pneumoniae pneumonia.","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R22-20260508","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/antibiotics11091233","article-title":"Macrolide versus non-macrolide in combination with steroids for the treatment of lobar or segmental Mycoplasma pneumoniae pneumonia unresponsive to initial macrolide monotherapy.","volume":"11","author":"Bae","year":"2022","journal-title":"Antibiotics"},{"key":"R23-20260508","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/jcm8050726","article-title":"Early corticosteroid therapy for Mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children.","volume":"8","author":"Yang","year":"2019","journal-title":"J Clin Med"},{"key":"R24-20260508","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children.","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"R25-20260508","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1542\/peds.2010-0983","article-title":"Adjunct corticosteroids in children hospitalized with community-acquired pneumonia.","volume":"127","author":"Weiss","year":"2011","journal-title":"Pediatrics"},{"key":"R26-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-05830-4","article-title":"Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy.","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R27-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2020.566371","article-title":"Low-dose corticosteroid treatment in children with Mycoplasma pneumoniae pneumonia: a retrospective cohort study.","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Pediatr"},{"key":"R28-20260508","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jiac.2019.01.003","article-title":"Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children.","volume":"25","author":"Okumura","year":"2019","journal-title":"J Infect Chemother"},{"key":"R29-20260508","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.resinv.2017.11.005","article-title":"Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections.","volume":"56","author":"Okubo","year":"2018","journal-title":"Respir Investig"},{"key":"R30-20260508","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2014.46.4.239","article-title":"Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: an observation study.","volume":"46","author":"Youn","year":"2014","journal-title":"Infect Chemother"},{"key":"R31-20260508","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children.","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"R32-20260508","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children.","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R33-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10061309","article-title":"Macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in children treated using early corticosteroids.","volume":"10","author":"Han","year":"2021","journal-title":"J Clin Med"},{"key":"R34-20260508","doi-asserted-by":"crossref","first-page":"33","DOI":"10.29271\/jcpsp.2022.01.33","article-title":"Effect of methylprednisolone plus azithromycin on fractional exhaled nitric oxide and peripheral blood eosinophils in children with refractory Mycoplasma pneumoniae pneumonia.","volume":"32","author":"Zhou","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"R35-20260508","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","article-title":"Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.","volume":"13","author":"Shan","year":"2017","journal-title":"World J Pediatr"},{"key":"R36-20260508","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/tropej\/fmu022","article-title":"Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial.","volume":"60","author":"Huang","year":"2014","journal-title":"J Trop Pediatr"},{"key":"R37-20260508","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia.","volume":"48","author":"Nagy","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"R38-20260508","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial.","volume":"185","author":"Tagarro","year":"2017","journal-title":"J Pediatr"},{"key":"R39-20260508","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ppul.25699","article-title":"Management of parapneumonic pleural effusion in children: is there a role for corticosteroids when conventional nonsurgical management fails? A single-center 15-year experience.","volume":"57","author":"Thimmesch","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R40-20260508","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ped.15603","article-title":"Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2.","volume":"65","author":"Ozsurekci","year":"2023","journal-title":"Pediatr Int"},{"key":"R41-20260508","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/cc10082","article-title":"Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus.","volume":"15","author":"Kil","year":"2011","journal-title":"Crit Care"},{"key":"R42-20260508","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/jmv.27680","article-title":"The difference in clinical features and prognosis of severe adenoviral pneumonia in children of different ages.","volume":"94","author":"Wang","year":"2022","journal-title":"J Med Virol"},{"key":"R43-20260508","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/17460913.3.6.635","article-title":"New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.","volume":"3","author":"Waites","year":"2008","journal-title":"Future Microbiol"},{"key":"R44-20260508","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/PEC.0000000000002984","article-title":"Impact of adjunct corticosteroid therapy on quality of life for children with suspected pneumonia.","volume":"39","author":"Navanandan","year":"2023","journal-title":"Pediatr Emerg Care"},{"key":"R45-20260508","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.annemergmed.2011.12.027","article-title":"Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation.","volume":"60","author":"Bhogal","year":"2012","journal-title":"Ann Emerg Med"},{"key":"R46-20260508","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.92.4.513","article-title":"Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma.","volume":"92","author":"Scarfone","year":"1993","journal-title":"Pediatrics"},{"key":"R47-20260508","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/591915","article-title":"The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.","volume":"198","author":"Tagliabue","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:00:28Z","timestamp":1778212828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005106","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}